Lack of long-term sustainable growth rate fix continues to frustrate urologists and other physicians

Article

As a result of a classic Washington decision just before Christmas, a 27.4% Medicare fee cut was delayed from its original Jan. 1 implementation date and is now scheduled, barring miraculous congressional action, to take effect on Feb. 29.

As a result of a classic Washington decision just before Christmas, a 27.4% Medicare fee cut was delayed from its original Jan. 1 implementation date and is now scheduled, barring miraculous congressional action, to take effect on Feb. 29.

Doing what they could to help physicians who are uncertain as to whether they should participate in Medicare, the Centers for Medicare & Medicaid Services extended its Dec. 31, 2011 deadline to Feb. 14, 2012 for physicians to notify the agency of their plans to participate in the coming year.

According to CMS, contractors will accept and process any participation elections or withdrawals made during the extended enrollment period that are postmarked on or before Feb. 14.

SGR problem remains

Certainly, the extension for a participation decision was helpful to many urologists.

However, without a meaningful decision on reforming the sustainable growth rate (SGR) formula, the root of all of this turmoil will remain. Unless that problem is resolved, uncertainty still hovers over the medical community like a heavy fog, forcing physicians to question whether they can afford to continue treating Medicare patients or whether it is time to begin sending out "Dear patient" letters, perhaps using the toolkit provided by the American Medical Association.

The AUA and other organizations representing urologists have repeatedly and strenuously urged lawmakers to stop procrastinating and avoiding the tough decision on how to cover the $300 billion cost of fixing the SGR.

With this brief reprieve from the massive 27% cut to Medicare payments, Congress now has to "enact a real and fiscally responsible solution to this sorry cycle of scheduled cuts and short-term patches that compromises access to care for patients and drives up costs for taxpayers," said AMA President Peter W. Carmel, MD, in a statement following Congress' 11th-hour reprieve in December. "Members of Congress need to use this time to work in a bipartisan manner to provide stability for seniors, military families, and the physicians who care for them."

In a statement, the American College of Surgeons said: "Access to the nation's health care system and the ability of physicians to provide care should not be viewed as political fodder."

Related Videos
Kevin M. Wymer, MD
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
Video 4 - "Androgen Receptor Signaling and Its Role in Driving Prostate Cancer Metastasis"
Video 3 - "Treatment Selection in Metastatic and Castration Resistant Prostate Cancer: Optimizing Outcomes and Preserving Patient Quality of Life"
Video 2 - "Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer"
Video 1 - "Metastatic Prostate Cancer: Background and Patient Prognosis"
Related Content
© 2024 MJH Life Sciences

All rights reserved.